ESPR
Esperion Therapeutics Inc
3.20$
+0.0%
vs. previous close
Closing price · As of: Jul 15, 2026
Statements
Cash Flow
Esperion Therapeutics Inc (ESPR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -13 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.9 | -18 | -23 | -27 | -9.1 | -11 | -18 | -32 | -38 | -48 | -131 | -149 | -70 | -85 | -264 | -175 | -135 | -24 | -13 | |
| -0.7 | -2.1 | -2.0 | -1.3 | 0.2 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.5 | 0.6 | 0.5 | 0.2 | 0.1 | 0.1 | |
| – | – | – | – | 0.1 | 0.1 | 1.2 | 3.7 | 13 | 16 | 19 | 24 | 26 | 28 | 24 | 15 | 12 | 12 | 9.9 | |
| – | – | – | – | – | – | 4.2 | 3.7 | 13 | 16 | 19 | 24 | 26 | 28 | 22 | 15 | – | – | – | |
| 1.9 | 3.0 | -1.1 | -0.5 | 0.8 | -0.8 | 3.2 | 0.3 | -2.1 | 10.0 | 16 | 29 | -7.3 | -4.3 | -53 | -3.4 | 14 | -61 | -15 | |
| 1.6 | 1.3 | 2.0 | 1.2 | 0.0 | 0.0 | 0.0 | 0.9 | 0.3 | 0.1 | 0.0 | 0.2 | 1.0 | 13 | 0.0 | 0.0 | 0.0 | 0.3 | 0.2 | |
| -1.6 | -2.0 | -2.1 | -5.5 | 0.5 | 0.0 | -21 | -37 | -160 | 10 | -36 | 140 | 64 | 21 | -50 | 8.1 | 43 | -0.3 | 0.2 | |
| – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 303 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | – | – | 72 | 92 | 191 | 0.0 | 165 | 12 | 12 | -55 | 222 | 91 | – | – | – | |
| – | – | – | – | – | – | – | 4.8 | -0.6 | -1.6 | -1.7 | -1.0 | 280 | 226 | -0.4 | 0.0 | 0.0 | 35 | -55 | |
| 2.8 | 84 | 25 | 1.4 | 6.7 | 16 | 89 | 97 | 191 | -1.6 | 163 | 11 | 136 | 202 | 268 | 33 | 50 | 86 | 36 | |
| -6.6 | 64 | 0.1 | -30 | -1.8 | 4.9 | 50 | 29 | -7.7 | -39 | -3.7 | 2.5 | 130 | 138 | -46 | -134 | -43 | 63 | 23 | |
| -9.4 | -19 | -25 | -28 | -9.1 | -11 | -18 | -33 | -38 | -48 | -131 | -149 | -71 | -99 | -264 | -175 | -135 | -24 | -13 |
Data as of: July 15, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.